These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3881304)

  • 1. Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin-dependent diabetic patients.
    Waldhäusl WK; Bratusch-Marrain P; Kruse V; Jensen I; Nowotny P; Vierhapper H
    Diabetes; 1985 Feb; 34(2):166-73. PubMed ID: 3881304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.
    Sakata S; Matsuda M; Komaki T; Miura K
    Immunol Invest; 1986 Dec; 15(8):791-9. PubMed ID: 3298026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose utilization in Type 1 (insulin-dependent) diabetes: Evidence for a defect not reversible by acute elevations of insulin.
    Proietto J; Nankervis A; Aitken P; Caruso G; Alford F
    Diabetologia; 1983 Oct; 25(4):331-5. PubMed ID: 6357915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.
    Lewis GF; Zinman B; Groenewoud Y; Vranic M; Giacca A
    Diabetes; 1996 Apr; 45(4):454-62. PubMed ID: 8603767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion.
    Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R
    Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.
    Gray RS; Cowan P; di Mario U; Elton RA; Clarke BF; Duncan LJ
    Br Med J (Clin Res Ed); 1985 Jun; 290(6483):1687-91. PubMed ID: 3924216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective free-fatty acid and oxidative glucose metabolism in IDDM during hypoglycemia. Influence of glycemic control.
    Caprio S; Amiel S; Tamborlane WV; Gelfand RA; Sherwin RS
    Diabetes; 1990 Feb; 39(2):134-41. PubMed ID: 2227120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin action in insulin-dependent diabetes mellitus (type I): measurement during constant and changing insulin concentrations.
    Doeden B; Rizza R
    J Lab Clin Med; 1988 Jul; 112(1):28-35. PubMed ID: 3292681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects.
    Hansen IL; Cryer PE; Rizza RA
    Diabetes; 1985 Aug; 34(8):751-5. PubMed ID: 3894118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes.
    Bruce DG; Chisholm DJ; Storlien LH; Kraegen EW
    Diabetes; 1988 Jun; 37(6):736-44. PubMed ID: 3289994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII.
    Koivisto VA; Yki-Järvinen H; Helve E; Karonen SL; Pelkonen R
    Diabetes; 1986 Jan; 35(1):78-82. PubMed ID: 3510143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
    Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
    J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.